MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the quarter ending 2025-12-31, CTOR has $109,973,406 in assets. $51,559,705 in debts.

Balance Sheets Overview

Current Ratio
83.08%
Quick Ratio
32.45%
Debt to Asset Ratio
46.88%
Assets Breakdown
    • In-process research and developm...
    • Inventory
    • Cash and cash equivalents
    • Others
Liabilities Breakdown
    • Additional paid-in capital
    • Accumulated deficit
    • License payable
    • Others

Unit: Dollar
Balance Sheets
2025-12-31
2025-09-30
2025-06-30
Cash and cash equivalents
7,295,451 3,924,908 112
Accounts receivable, net of allowances
4,049,111 --
Inventory
22,639,342 22,286,693 17,208,967
Prepaid expenses
3,162,940 1,331,280 1,100,000
Total current assets
37,146,844 27,542,881 18,309,079
In-process research and development, net of accumulated amortization
72,826,562 73,400,000 73,400,000
Total other assets
72,826,562 73,400,000 73,400,000
Total assets
109,973,406 100,942,881 91,709,079
Accounts payable
10,446,900 13,234,684 8,667,419
License payable
18,250,000 22,650,000 28,400,000
Accrued expenses
4,518,916 4,093,124 8,458,554
Due to related party-Related Party
11,494,578 9,513,771 7,464,362
Total current liabilities
44,710,394 49,491,579 52,990,335
Deferred tax liability
3,049,200 2,784,960 2,520,720
Note payable to related party-Related Party
3,800,111 3,800,111 3,800,111
Total liabilities
51,559,705 56,076,650 59,311,166
Common stock - 0.0001 par value 400,000,000 shares authorized at december 31, 2025 and september 30, 2025 84,797,846 and 83,513,442 shares issued and outstanding at december 31, 2025 and september 30, 2025, respectively
8,480 8,351 7,155
Additional paid-in capital
127,979,246 108,897,836 91,434,058
Accumulated deficit
-69,574,025 -64,039,956 -59,043,300
Total stockholders equity
58,413,701 44,866,231 32,397,913
Total liabilities and stockholders equity
109,973,406 100,942,881 91,709,079
Unit: Dollar

Time Plot

Show the time plot by selecting a row from the table.

Balance Sheets

In-process research anddevelopment, net of...$72,826,562 Prepaid expenses$3,162,940 Inventory$22,639,342 Accounts receivable, netof allowances$4,049,111 Cash and cashequivalents$7,295,451 Total other assets$72,826,562 Total current assets$37,146,844 Total assets$109,973,406 Total liabilities andstockholders equity$109,973,406 Total stockholdersequity$58,413,701 Total liabilities$51,559,705 Accumulated deficit-$69,574,025 Additional paid-in capital$127,979,246 Note payable torelated party-Related...$3,800,111 Deferred tax liability$3,049,200 Total currentliabilities$44,710,394 Common stock - 0.0001par value...$8,480 Due to relatedparty-Related Party$11,494,578 Accrued expenses$4,518,916 License payable$18,250,000 Accounts payable$10,446,900

CITIUS ONCOLOGY, INC. (CTOR)

CITIUS ONCOLOGY, INC. (CTOR)